APA (7th ed.) Citation

Harbeck, N., & Schneeweiss, A. (2013). HER2 dimerization inhibitor pertuzumab: Mode of action and clinical data in breast cancer. Breast care, 8(1), . https://doi.org/10.1159/000346837

Chicago Style (17th ed.) Citation

Harbeck, Nadia, and Andreas Schneeweiss. "HER2 Dimerization Inhibitor Pertuzumab: Mode of Action and Clinical Data in Breast Cancer." Breast Care 8, no. 1 (2013). https://doi.org/10.1159/000346837.

MLA (9th ed.) Citation

Harbeck, Nadia, and Andreas Schneeweiss. "HER2 Dimerization Inhibitor Pertuzumab: Mode of Action and Clinical Data in Breast Cancer." Breast Care, vol. 8, no. 1, 2013, https://doi.org/10.1159/000346837.